Rankings
▼
Calendar
RYTM FY 2025 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$190M
+45.8% YoY
Gross Profit
$170M
89.7% margin
Operating Income
-$192M
-101.2% margin
Net Income
-$197M
-103.6% margin
EPS (Diluted)
$-3.11
Cash Flow
Operating Cash Flow
-$116M
Free Cash Flow
-$117M
Stock-Based Comp.
$67M
Balance Sheet
Total Assets
$481M
Total Liabilities
$342M
Stockholders' Equity
$139M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$190M
$130M
+45.8%
Gross Profit
$170M
$117M
+45.8%
Operating Income
-$192M
-$266M
+27.7%
Net Income
-$197M
-$261M
+24.6%
← Q4 2024
All Quarters
Q1 2025 →